Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Follicular Lymphoma ( FL)”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Testing effectiveness (Phase 2)Looking for participantsNCT06792825
What this trial is testing

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

Who this might be right for
Follicular LymphomaMarginal Zone Lymphoma
Masonic Cancer Center, University of Minnesota 65
Testing effectiveness (Phase 2)Ended earlyNCT05720052
What this trial is testing

MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Relapsed or Refractory B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+4 more
MingSight Pharmaceuticals, Inc 8
Early research (Phase 1)Study completedNCT03610061
What this trial is testing

A Trial of Radiotherapy and Durvalumab in DLBCL and FL

Who this might be right for
Diffuse Large B Cell LymphomaFollicular Lymphoma
Austin Health 34
Testing effectiveness (Phase 2)Ended earlyNCT03768505
What this trial is testing

Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)

Who this might be right for
Follicular Lymphoma (FL)Non Hodgkin LymphomaMarginal Zone Lymphoma
MEI Pharma, Inc. 169
Testing effectiveness (Phase 2)Study completedNCT02611323
What this trial is testing

Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 133
Early research (Phase 1)Looking for participantsNCT04594642
What this trial is testing

AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non Hodgkin LymphomaDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma+1 more
AstraZeneca 317
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07031700
What this trial is testing

A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL

Who this might be right for
Relapsed/Refractory Follicular Lymphoma
Tianjin Medical University Cancer Institute and Hospital 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128641
What this trial is testing

Odronextamab in Low Tumor Volume Advanced FL

Who this might be right for
Follicular LymphomaLymphoma
Gottfried von Keudell, MD PhD 35
Not applicableStudy completedNCT04160442
What this trial is testing

Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL

Who this might be right for
Diffuse Large B Cell LymphomaFollicular Lymphoma
Carevive Systems, Inc. 46
Testing effectiveness (Phase 2)Looking for participantsNCT07077512
What this trial is testing

Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Large B Cell Diffuse LymphomaMantle Cell Lymphoma (MCL)Follicular Lymphoma ( FL)
Sun Yat-sen University 30
Large-scale testing (Phase 3)Looking for participantsNCT06191744
What this trial is testing

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Genmab 1,095
Testing effectiveness (Phase 2)Study completedNCT03610724
What this trial is testing

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 34
Large-scale testing (Phase 3)Ended earlyNCT02204982
What this trial is testing

Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
SecuraBio 13
Early research (Phase 1)Looking for participantsNCT05131022
What this trial is testing

NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Diffuse Large B Cell Lymphoma (DLBCL)+6 more
Nurix Therapeutics, Inc. 572
Large-scale testing (Phase 3)Active Not RecruitingNCT02390869
What this trial is testing

Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients

Who this might be right for
Lymphoma, Follicular
Fondazione Italiana Linfomi - ETS 128
Early research (Phase 1)Ended earlyNCT02931110
What this trial is testing

Study of IV CBL0137 in Previously Treated Hematological Subjects

Who this might be right for
Hematological Malignancies
Incuron 5
Testing effectiveness (Phase 2)Ended earlyNCT02440685
What this trial is testing

Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Follicular+18 more
Asana BioSciences 51
Not applicableLooking for participantsNCT07154823
What this trial is testing

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukaemia (AML)Follicular Lymphoma ( FL)
Tempus AI 550
Not applicableEnded earlyNCT04342117
What this trial is testing

Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL

Who this might be right for
Lymphoma, Small LymphocyticLymphomaLymphoma, Non-Hodgkin+2 more
SecuraBio 2
Testing effectiveness (Phase 2)Ended earlyNCT03135262
What this trial is testing

Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Follicular LymphomaLymphoma, Large B-Cell, Diffuse
Hoffmann-La Roche 29
Load More Results